You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 16 No. 2, February 1967 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (506)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Lithium As a Prophylactic Agent

Its Effect Against Recurrent Depressions and Manic-Depressive Psychosis

Poul Christian Baastrup, MD; Schou Mogens, MD

Arch Gen Psychiatry. 1967;16(2):162-172.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE SPECIFIC therapeutic effect of lithium in manic phases of the manicdepressive psychosis was first observed in 19491 and was confirmed later in controlled studies,2,3 as well as in a number of uncontrolled ones. A prophylactic action of the drug against both the manic and depressive phases of the illness could be noted in a few of the patients described by Schou et al.2 More systematic and detailed observations of this effect were made independently by Hartigan4 and Baastrup,5 and the term normothymotics was proposed for drugs with a specific action against manic-depressive psychosis.6

In order to demonstrate prophylactic drug action in a disorder such as manicdepressive psychosis, which is characterized by a capricious and largely unpredictable course, one must study a large number of patients who have a sufficiently high risk of relapse and who are observed for . . . [Full Text PDF of this Article]


Author Affiliations

Glostrup, Risskov, Denmark

From the Psychiatric Hospital, Glostrup (Dr. Baastrup); and the Psychopharmacology Research Unit, Institute of Psychiatry, Risskov, and Aarhus University School of Medicine (Dr. Schou).


Footnotes

Submitted for publication July 8, 1966.

Reprint requests to the Psychopharmacology Research Unit, Institute of Psychiatry, Risskov, Denmark (Dr. Schou).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1967 American Medical Association. All Rights Reserved.